Emily Charrier
Université de Montréal
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Emily Charrier.
Bone Marrow Transplantation | 2013
Emily Charrier; Paulo Cordeiro; R-M Brito; Samira Mezziani; Sabine Herblot; F. Le Deist; Michel Duval
Some clinical characteristics of cord blood transplantation (CBT) might be explained by specificities in the reconstitution of immune subsets differing by their maturation stage or their implication in GVHD, tolerance or immune responses against tumor or infectious agents. Here, we compare the immune reconstitution of several of these subsets after CBT and BMT. B-cell count recovery was faster after CBT. There was no difference in the recovery of CD4+ and CD8+ cell counts. There was no difference either in the frequency of several subsets: CD45RO+ memory, and CD45RA+ naïve cells within the CD4+ T-cell compartment, CD27+ among B cells, CD56bright, NKG2A+, and KIR+ cells among natural killer (NK) cells, CD25+FOXP3+ regulatory T cells and invariant NKT cells. The proportion of the thymic naïve CD31+CD45RA+CD4+ T cells was lower after CBT at 6 months post-transplant, and was still below normal at 1 year in both groups. NK-cell expansion was more sustained after CBT, with fewer double-negative NKG2A−KIR− hyporesponsive cells and more double-positive NKG2A+KIR+ hyper-responsive NK cells. These results, therefore, indicate that further research to improve CBT outcome should try to improve thymopoieisis and take advantage of the sustained NK-cell reconstitution.
Cellular Immunology | 2012
Emily Charrier; Paulo Cordeiro; Martine Cordeau; R’Kia Dardari; Annie Michaud; Michaël Harnois; Natacha Merindol; Sabine Herblot; Michel Duval
Plasmacytoid dendritic cells (PDCs) from human umbilical cord blood (UCB) produce lower amounts of IFN-α upon TLR stimulation compared with adult counterparts. This difference may play a role in the low graft-versus-host disease rate after UCB transplantation and in the impaired immune response of the neonate to pathogens. Comparing UCB PDC to their adults counterparts, we found that they exhibited a mature surface phenotype and a normal antigen uptake. They upregulated costimulatory molecules upon activation, although with delayed kinetics. Protein, but not ARN, levels of TLR-9, MyD88, IRAK1 and IRF-7, involved in the TLR-9 signaling pathway were reduced. The expression levels of miR-146a and miR-155, known to be involved in the post-transcriptional down-regulation of immune responses, were higher. These data point out a post-transcriptional down-regulation of the TLR-9/IRF-7 signaling pathway in UCB PDC.
Journal of Leukocyte Biology | 2011
Natacha Merindol; Emily Charrier; Michel Duval; Hugo Soudeyns
UCBT has been used for almost 25 years to treat a variety of malignant and nonmalignant childhood diseases. The biological properties of NK cells and T cells and their implication in engraftment, immune reconstitution, OIs, leukemic relapse, and GvHD have been explored in the context of UCBT. These studies have established that lymphocytes have a major impact on the outcome of UCBT and that NK cells and T cells play complementary and contrasting roles in immune reconstitution and the GvL effect. Therefore, novel strategies to improve the outcome of UCBT recipients, including immunotherapeutic regimens, should be based on key immunologic features of UCB T lymphocytes and NK cells.
Journal of Immunotherapy | 2010
Annie Michaud; RʼKia Dardari; Emily Charrier; Paulo Cordeiro; Sabine Herblot; Michel Duval
Lymphoid differentiation and activation critically depend on cytokine stimulation and the interleukin-7 (IL-7) signaling in particular. Although it has been demonstrated that IL-7 may play a role in natural killer (NK) cell maturation, the effect of IL-7 stimulation on mature human NK cells has not been studied. We, therefore, investigated the expression and functional activity of IL-7Rα on mature NK populations from adult blood. In this article, we demonstrate that IL-7Rα is specifically expressed in the CD56bright noncytotoxic cytokine-producing NK subset. Importantly, this expression is thymus independent, contrary to what is observed in mice. In addition, we show that IL-7Rα is expressed at higher levels on NKG2A+CD56bright NK cells. In contrast to IL-15 stimulation, IL-7 does not increase NK cell cytotoxicity, interferon-γ production, or the expression of activation markers, indicating that these cytokines play different functions in NK homeostasis and activation. However, IL-7 promotes the survival of the CD56bright NK subset and inhibits apoptosis by increasing BCL2 expression. These data should be taken into account when considering the clinical use of IL-7, particularly after stem cell transplantation.
Journal of Immunology | 2010
Natacha Merindol; Anne-Julie Grenier; Martine Caty; Emily Charrier; Arnaud Duval; Michel Duval; Martin A. Champagne; Hugo Soudeyns
Umbilical cord blood (UCB) is increasingly used as a source of hematopoietic progenitor cells to treat a variety of disorders. UCB transplant is associated with comparatively reduced incidence of graft-versus-host disease, robust graft versus leukemia effect, and relatively high incidence of opportunistic infections, three processes in which donor-derived T lymphocytes are known to be predominantly involved. To examine the differential functionality of UCB T cells, CD8+ T cells specific for the melanoma-associated HLA-A2–restricted Melan-A26–35 A27L peptide were isolated from HLA-A2+ and HLA-A2− UCB samples and HLA-A2+ and HLA-A2− adult peripheral blood using A2/Melan-A tetramers. In UCB samples, A2/Melan-A+ CD8+ T cells were detected at a frequency of 0.04%, were more frequent in HLA-A2+ UCB, and were polyclonal and mostly naive. Consistent with Ag-driven expansion, the frequency of A2/Melan-A+ CD8+ T cells was increased following stimulation with cognate peptide or polyclonal activation, they acquired cell-surface markers reflective of effector/memory differentiation, their TCR repertoire became oligoclonal, and they expressed cytolytic activity and produced IFN-γ. Although functional properties of A2/Melan-A+ CD8+ T cells derived from HLA-A2+ UCB resembled those of HLA-A2+ adult peripheral blood, they were more likely to reach terminal differentiation following polyclonal stimulation and produced less IFN-γ in response to cognate peptide. A2/Melan-A+ CD8+ T cells from HLA-A2− UCB were poorly cytolytic, produced little IFN-γ, and were predominantly monofunctional or nonfunctional. These properties of UCB-derived CD8+ T cells could contribute to the reduced incidence of graft-versus-host disease and heightened incidence of opportunistic infections observed following UCB transplant.
Immunological Investigations | 2012
Martine Cordeau; Sabine Herblot; Emily Charrier; François Audibert; Paulo Cordeiro; Michaël Harnois; Michel Duval
Physiological modulation of the immune system is required for foetal tolerance during pregnancy. However, this immune regulation might lead to impaired self-defence against pathogens. Indeed, pregnant women are more susceptible to newly encountered viruses comparing to non-pregnant women, as exemplified by the prevalence of severe complications in pregnant women infected with the pandemic influenza virus in 2009. Plasmacytoid dendritic cells (pDCs) are specialized dendritic cells that recognise viral antigens and initiate both innate and adaptive immune responses. We therefore sought to determine whether the number and/or the functions of peripheral blood pDCs are regulated during pregnancy. pDC maturation and interferon (IFN)-α production were analysed in response to Toll-like receptor (TLR) stimulation of peripheral blood mononuclear cells from pregnant and non-pregnant women. Our results reveal that pDC frequency is slightly decreased, while the IFN-α production in response to TLR stimulation increases during pregnancy. Interestingly, the up-regulation of the co-stimulatory receptors CD54 (ICAM1) and CD86 is significantly decreased in pDCs from pregnant women as compared to controls, suggesting a possible impact on T-cell responses. In conclusion, we propose that the modulation of CD54 and CD86 expression on peripheral blood pDCs during pregnancy might decrease the initiation of adaptive antiviral immune responses.
Journal of Immunology | 2012
Natacha Merindol; Insaf Salem Fourati; Rose-Marie Brito; Anne-Julie Grenier; Emily Charrier; Paulo Cordeiro; Martine Caty; Samira Mezziani; Brigitte Malette; Michel Duval; Carolina Alfieri; Philippe Ovetchkine; Françoise Le Deist; Hugo Soudeyns
CMV and varicella zoster virus (VZV) are significant causes of morbidity and mortality following umbilical cord blood transplantation (UCBT). However, the kinetics of reconstitution and protective potential of antiviral cell-mediated immune responses following UCBT remain poorly characterized. In this study, the reconstitution of CMV- and VZV-specific T cell responses was assessed using IFN-γ ELISPOT in 28 children who underwent UCBT to treat hematological or inherited disorders. Barely detectable in the first 3 mo posttransplantation, CMV- and VZV-specific T cell responses were observed in 30.4% and 40.3% of study subjects after 36 mo of follow-up. Four of five CMV-seropositive subjects developed detectable levels of circulating CMV DNA (DNAemia), and 5 of 17 VZV-seropositive patients experienced herpes zoster during the posttransplant period. Four CMV-seronegative subjects developed IFN-γ responses against CMV, and four subjects developed a VZV-specific IFN-γ response without clinical signs of infection. No CMV- or VZV-related events were observed in study subjects following the development of CMV- or VZV-specific responses > 150 spot-forming units/106 PBMCs, consistent with T cell-mediated protection. Finally, famciclovir prophylaxis did not strictly prevent the reconstitution of the VZV-specific T cell repertoire, because the frequency of T cells producing IFN-γ in response to VZV Ags reached levels consistent with protection in two nonzoster subjects. Monitoring of CMV- and VZV-specific cell-mediated immunity could inform immunocompetence and guide the initiation and cessation of antiherpetic prophylaxis in UCBT recipients.
Biology of Blood and Marrow Transplantation | 2014
Emily Charrier; Paulo Cordeiro; Rose-Marie Brito; Michaël Harnois; Samira Mezziani; Sabine Herblot; Françoise Le Deist; Michel Duval
M S-medecine Sciences | 2007
Emily Charrier; Rkia Dardari; Annie Michaud; Paulo Cordeiro; Michel Duval
Journal of Immunology | 2012
Hugo Soudeyns; Insaf Salem Fourati; Rose-Marie Brito; Emily Charrier; Paulo Cordeiro; Martine Caty; Samira Mezziani; Brigitte Malette; Michel Duval; Carolina Alfieri; Philippe Ovetchkine; Françoise Le Deist; Natacha Merindol